Chad Therapeutics Reports Decline in 4th Quarter

Chad Therapeutics Inc. reported a net loss for the fourth quarter ended March 31 of $1.2 million compared with a net loss of $679,000 for the same period the previous year. Revenue decreased 9% to $2.8 million, compared with $3 million. For the year ended March 31, the company reported a net loss of $2.5 million, compared with a net loss of $1.5 million the previous year. Revenue dipped to $12.8 million from $14 million.

Chad Therapeutics makes oxygen conserving devices and systems for pulmonary patient care.